ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 2 filers reported holding ALBIREO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $406,000 | -18.8% | 20,300 | +31.0% | 0.07% | -21.7% |
Q2 2019 | $500,000 | +8.9% | 15,500 | +8.8% | 0.09% | +9.5% |
Q1 2019 | $459,000 | +54.5% | 14,250 | +17.8% | 0.08% | +35.5% |
Q4 2018 | $297,000 | -31.2% | 12,100 | -7.6% | 0.06% | -17.3% |
Q3 2018 | $432,000 | -9.2% | 13,100 | -2.2% | 0.08% | -12.8% |
Q2 2018 | $476,000 | +44.7% | 13,400 | +32.7% | 0.09% | +38.7% |
Q1 2018 | $329,000 | +36.5% | 10,100 | +7.4% | 0.06% | +37.8% |
Q4 2017 | $241,000 | -24.2% | 9,400 | -38.2% | 0.04% | -27.4% |
Q3 2017 | $318,000 | +1.6% | 15,200 | 0.0% | 0.06% | -4.6% |
Q2 2017 | $313,000 | – | 15,200 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
PA Capital LLC | 14,692 | $360,000 | 0.38% |
Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |